Prevalence, progress, and subgroup disparities in pharmacological antidepressant treatment of those who screen positive for depressive symptoms: A repetitive cross-sectional study in 19 European countries.
Lancet Reg Health Eur
; 17: 100368, 2022 Jun.
Article
en En
| MEDLINE
| ID: mdl-35373171
ADL, activities of daily living; AOR, adjusted odds ratio; ARC, applied research collaboration; Antidepressants; BNF, British national formulary; CI, confidence interval; Depression; Disparity; EMHAP, European mental health action plan; European; GDP, gross domestic product; GHQ-12, 12-item general health questionnaire; GNI, gross national income per capita; GP, general practitioner; HSE, health survey for England; IAPT, improving access to psychological therapies; IMD, index of multiple deprivation; NHS, National Health Service; NIHR, National Institute for Health Research; OR, odds ratio; SHARE, survey of health, ageing and retirement in Europe; STROBE, strengthening the reporting of observational studies in epidemiology; UK, United Kingdom; USA, United States of America; WHO, World Health Organization
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Diagnostic_studies
/
Observational_studies
/
Prevalence_studies
/
Prognostic_studies
/
Risk_factors_studies
Aspecto:
Equity_inequality
Idioma:
En
Revista:
Lancet Reg Health Eur
Año:
2022
Tipo del documento:
Article
País de afiliación:
Reino Unido
Pais de publicación:
Reino Unido